UnitedHealth Group analyst views diverge, shares hover near 52-week high
23.06.2026 - 07:36:16 | ad-hoc-news.de
By Christina Vogel, Background & Management desk. Reviewed prior to publication on 2026-06-23, 07:33.
UnitedHealth Group (US91324P1021) remains a key healthcare weight in the S&P 500 as Wall Street revises its expectations around growth, margins and valuation. The NYSE-listed shares trade close to their 52-week high, according to recent analyst and market data.
What recent analyst notes show
TD Cowen recently cut its price target on UnitedHealth Group shares, citing a lower core growth outlook and challenges in behavioral health licensing while maintaining a Buy recommendation, as summarized by an Investing.com report that also highlights benefits from Florida's State Directed Payment program and a current share price around 404 dollars near a 52-week peak and a roughly 367 billion dollar market capitalization for the S&P 500 constituent. Investing.com details the TD Cowen target cut and valuation metrics
The same analyst roundup notes that Leerink Partners lifted its price target to 462 dollars from 400 dollars with an Outperform rating, while Bernstein increased its target from 444 dollars to 492 dollars and reiterated Outperform, referencing a more favorable earnings outlook from Medicare Advantage recovery and a transparent pharmacy benefit manager model at Optum that aims for clearer drug pricing. The same Investing.com piece summarizes the Leerink and Bernstein updates
Consensus picture on Tuesday
Across Wall Street, UnitedHealth Group still carries a predominantly positive analyst stance, with a mix of Buy and Hold recommendations reflected in recent consensus snapshots that point to expectations of ongoing earnings growth, even as some houses trim assumptions for specific segments such as behavioral health and adjust valuation multiples to reflect updated regulatory and reimbursement views. An overview on Intellectia.ai cites 19 analyst ratings with a majority Buys
Market data aggregators show UnitedHealth Group trading a little above 406 dollars on the NYSE with a one-day gain of around 1.4 percent into the June 22 close, underscoring the resilience of the shares within the U.S. managed-care peer group that includes names such as Humana and Elevance Health. MarketBeat quotes a 406.60 dollar close for UNH on June 22
All news and data on the UnitedHealth Group shares
Track current UNH pricing, filings and analyst views alongside earlier earnings reports and regulatory updates.
How UnitedHealth Group earns its money
UnitedHealth Group generates most of its revenue through its UnitedHealthcare insurance segment, which offers commercial, Medicare Advantage and Medicaid plans in the United States, while the Optum unit provides pharmacy benefit management, health services and data analytics, giving the group diversified exposure to U.S. healthcare spending. The company’s investor materials break down revenue between UnitedHealthcare and Optum
Where the shares trade today
UnitedHealth Group shares (US91324P1021) last traded at 406.68 dollars on the NYSE as of 2026-06-22, 21:59, according to consolidated quote data.
Key data on the UnitedHealth Group shares
- Company: UnitedHealth Group Incorporated
- ISIN: US91324P1021
- WKN: 869561
- Ticker: UNH
- Trading venue: NYSE
- Price (as of 2026-06-22, 21:59): 406.68 USD
- Market cap: 367.0 billion USD (as of 2026-06-22)
- Sector / industry: Health Care / Managed Health Care
- Index membership: S&P 500, Dow Jones Industrial Average, S&P 100
- Next earnings date: not officially scheduled
Disclaimer: This article is for informational purposes only and does not constitute investment advice, investment recommendation or an offer to buy or sell any financial instrument. Investors should conduct their own research and consider their individual financial situation before making investment decisions.
